These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8067083)

  • 21. [Yersinia pestis L-forms in rodents and ectoparasites].
    Zykin LF; Dunaev GS; Saiamov SR; Sokolov PS
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Feb; (2):36-40. PubMed ID: 2728699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge.
    Wang T; Qi Z; Wu B; Zhu Z; Yang Y; Cui B; Dai R; Zhang Q; Qiu Y; Wang Z; Wang H; Guo Z; Wang X; Yang R
    Protein Expr Purif; 2008 Sep; 61(1):7-12. PubMed ID: 18539482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The dependence of the inducing action of Yersinia pestis antigens on cachectin synthesis and production by mouse mononuclear phagocytes].
    Kiselev IuL; Isin ZhM; Tugambaev TI; Dmitrovskiĭ AM
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):81-2. PubMed ID: 8079585
    [No Abstract]   [Full Text] [Related]  

  • 24. [Isolation and purification of Yersinia pestis neuraminidase].
    Shimaniuk NIa; Mishan'kin BN
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):70-4. PubMed ID: 6637277
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunogenicity of Yersinia pestis grown on nutrient media at 28 and 37 degrees C].
    Sheremet OV; Miliutin VN; Terent'ev AN; Morozova LN
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):63-8. PubMed ID: 3673377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAP of F1 and V antigens from Yersinia pestis astride innate and adaptive immune response.
    Rai R; Das B; Choudhary N; Talukdar A; Rao DN
    Microb Pathog; 2015 Oct; 87():13-20. PubMed ID: 26188288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The phenomenon of pilus formation in the interaction of Yersinia pestis with macrophages in experimental animals].
    Vodop'ianov SO; Popova GO; Vasil'eva GI; Mishan'kin BN
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Mar; (3):3-6. PubMed ID: 1973326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Isolation of monoclonal antibodies for the identification of strains of the causative agent of plague that do not contain a capsular antigen].
    Zaĭtsev AA; Vikhrev NE; Sazykin AIu; Vengerova IuIu; Levi MI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Aug; (8):76-9. PubMed ID: 2511708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and assembly of Yersinia pestis F1 antigen.
    Knight SD
    Adv Exp Med Biol; 2007; 603():74-87. PubMed ID: 17966405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The isolation and characteristics of variant plague microbes not producing the capsular antigen].
    Gvozdenko NA; Ryzhkov VIu; Pavlovich NV
    Mikrobiol Zh (1978); 1990; 52(6):13-7. PubMed ID: 2097497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunochemical characteristics of the autoagglutination factor of plague pathogen].
    Rykova VA; Lysova LK; Podladchikova ON
    Klin Lab Diagn; 2009 Mar; (3):19-22. PubMed ID: 19388480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of different Yersinia pestis antigens on the cellular link in immunity].
    Isupov IV; Nazarova LS; Pavlova LP; Gor'kova AV; Revazova ES; Dushkin VA; Zadumina SIu; Surikov NN; Taranenko TM; Dzhaparidze MN
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Sep; (9):85-9. PubMed ID: 2256408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Basic somatic antigen or antigen obtained from Yersinia pestis by the Boivin-Mesrobeanu method].
    Griboedov AV; Barabash GP
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Mar; (3):108-15. PubMed ID: 2581401
    [No Abstract]   [Full Text] [Related]  

  • 35. Transcriptional analysis of the Yersinia pestis pH 6 antigen gene.
    Price SB; Freeman MD; Yeh KS
    J Bacteriol; 1995 Oct; 177(20):5997-6000. PubMed ID: 7592356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The use of the macrophage disappearance reaction for detecting delayed hypersensitivity to Yersinia pestis antigens].
    Vasil'eva GI; Doroshenko EP; Kiseleva AK; Pustovalov VL
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):83-6. PubMed ID: 2099076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular modeling of the steric structure of the envelope F1 antigen of Yersinia pestis.
    Zav'yalov V; Denesyuk A; Zav'yalova G; Korpela T
    Immunol Lett; 1995 Feb; 45(1-2):19-22. PubMed ID: 7542626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the antigenic subunits of the envelope protein of Yersinia pestis.
    Bennett LG; Tornabene TG
    J Bacteriol; 1974 Jan; 117(1):48-55. PubMed ID: 4203000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and biological properties of soluble protein preparations from Brucella abortus.
    Tabatabai LB; Deyoe BL
    Dev Biol Stand; 1984; 56():199-211. PubMed ID: 6436094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis.
    Khan AA; Babu JP; Gupta G; Rao DN
    Vaccine; 2008 Jan; 26(3):316-32. PubMed ID: 18096277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.